{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:12:58Z","timestamp":1760919178723,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jceh.2024.101356","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T19:46:02Z","timestamp":1706816762000},"page":"101356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-0055","authenticated-orcid":false,"given":"Jaime","family":"Bosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101356_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101356_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.101356_bib3","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","author":"Kaplan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101356_bib5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2024.101356_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101356_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/hep.26629","article-title":"Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study","volume":"58","author":"Ripoll","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40644-024-00657-z","article-title":"Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion","volume":"24","author":"Balcar","year":"2024","journal-title":"Cancer Imag"},{"key":"10.1016\/j.jceh.2024.101356_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HEP.0000000000000538","article-title":"Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC","volume":"79","author":"Senzolo","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/HEP.0000000000000291","article-title":"Portal hypertension and variceal bleeding in patients with liver cancer: evidence gaps for prevention and management","volume":"79","author":"Allaire","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","article-title":"Treatment of portal hypertension in patients with HCC in the era of Baveno VII","volume":"78","author":"Thabut","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101356_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2020.09.018","article-title":"Small diameter shunts should lead to safe expansion of the use of TIPS","volume":"74","author":"Bosch","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101356_bib14","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1007\/s00330-022-08705-7","article-title":"TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension","volume":"32","author":"Qiu","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jceh.2024.101356_bib15","first-page":"1838","article-title":"Effect of transjugular intrahepatic portosystemic shunt combined with 125I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma","volume":"14","author":"Han","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jceh.2024.101356_bib16","doi-asserted-by":"crossref","first-page":"101305","DOI":"10.1016\/j.jceh.2023.101305","article-title":"Transjugular intrahepatic portosystemic shunt for advanced hepatocellular carcinoma with main portal vein tumor thrombus-related symptomatic portal hypertension","volume":"14","author":"Xie","year":"2024","journal-title":"J\u00a0Clin Exper Hepatol"},{"key":"10.1016\/j.jceh.2024.101356_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.101356_bib18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hep.29320","article-title":"The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B","volume":"66","author":"Papatheodoridis","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101356_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after\u00a0transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:12:53Z","timestamp":1760854373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324000136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0973688324000136"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101356","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.101305","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101356"}}